Skip to main content

Starr Indemnity & Liability Co

13F filer · CIK 0001640521
Reported Aug 11, 2026
Net buyer this quarter
13F portfolio value$377MU.S. long equity reported on 13F
Positions20 new · 0 closed
Net flow last quarter+$4.27MBuys minus sells
Top 10 positions weight74.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 11, 20262 positions
GLDSPDR Gold Trust$228M60.48%0.17%+1.9%Q4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$53.9M14.31%Not reportedNot reportedQ2 2025
Q1 2026Reported May 11, 20262 positions
GLDSPDR Gold Trust$261M66.41%0.16%+8.0%Q4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$50.6M12.87%Not reportedNot reportedQ2 2025
Q4 2025Reported Feb 9, 20262 positions
GLDSPDR Gold Trust$223M63.29%0.15%+11.5%Q4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$50M14.20%Not reportedNot reportedQ2 2025
Q3 2025Reported Nov 12, 20252 positions
GLDSPDR Gold Trust$179M58.55%0.15%Not reportedQ4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$48.6M15.87%Not reportedNot reportedQ2 2025
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.